Stay updated on Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedPage revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page, indicating a minor document update.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2; no substantive study content, endpoints, or locations were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision label changed from v3.4.0 to v3.4.1 with no impact on content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check89 days agoChange DetectedAdded standalone 'Results First Posted' and 'Last Update Posted' timestamps and removed the '(Estimated)' qualifiers for those fields. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.